Furthermore, no statistically significant differences in XPO1 expression were detected by comparing lymphomas with high cytoplasmic to specimens with low or no cytoplasmic NR4A1 levels (p = 0.601, Fig. 2d) suggesting that overexpression of XPO1 might not be the sole reason for the cytoplasmic localization of NR4A1 in aggressive lymphomas. The gene discussed is XPO1; the disease is lymphoma.